For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts
Oneindia App Download

Most anticipated COVID-19 drug, remdesivir cleared for use in severe cases

|
Google Oneindia News

New Delhi, June 02: The use of anti-viral medication, remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 cases has been cleared by India's top drug regulatory body.

One of the most closely watched drugs in the global clinical trials, remdesivir was approved by the Drug Controller General of India for administration as part of a maximum five day regimen, reports say.

Most anticipated COVID-19 drug, remdesivir cleared for use in severe cases

Recommended Video

WHO says Sars-Cov-2 is still a killer virus, rejects 'losing potency' claim | Oneindia News

The drug is manufactured by the American biopharma giant, Gilead Sciences. It would be imported by the Mumbai based Klineria Global Services from the manufacturing sites of Gilead.

Remdesivir improves time to recovery in COVID-19 patients: StudyRemdesivir improves time to recovery in COVID-19 patients: Study

Reports also say that the Central Drugs Standard Control Organisation has decided against extending the use of the drug to 10 days, based on existing evidence presented to it at the time of approval.

The approval now paves the way for generic voluntary licence holders in the country to manufacture the drug. An Indian Express report said that the restriction of the drug to five days will save patients a lot of money.

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X